Misadventures in insulin therapy: Are you at risk?

Journal of the National Medical Association

Volumn 95, Issue 2 SUPPL. 1, 2003, Pages

  Grissinger, Matthew ^b   Lease, Michael ^a  

^a GMR Group   (United States)

^b NONE

Author keywords

Diabetes; Glycemia; Insulin therapy

Indexed keywords

HUMAN INSULIN; HUMULIN L; HUMULIN U; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NEUTRAL INSULIN; NOVOLIN R; UNCLASSIFIED DRUG; VELOSULIN BR; ANTIDIABETIC AGENT;

BLINDNESS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIABETES CONTROL; DISEASE ACTIVITY; DISEASE COURSE; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG SELF ADMINISTRATION; ERROR; GLUCOSE BLOOD LEVEL; HEART DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; JET INJECTION; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACODYNAMICS; PHYSICIAN ATTITUDE; POSTPRANDIAL STATE; PRACTICE GUIDELINE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELF INJECTION; SYRINGE; ADULT; BLOOD; BLOOD GLUCOSE MONITORING; CHILD; CLASSIFICATION; DIABETES MELLITUS; HUMAN; INSTRUMENTATION; MEDICATION ERROR; METHODOLOGY; RISK FACTOR; SELF CARE; STANDARD; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; RISK FACTORS; SELF CARE;

EID: 0037317703     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Facts and Statistical Information Related to Diabetes. http://www.cdc.gov/diabetes/pubs/facts/98.htm. Accessed 10 April 2002.
2. Weck M, Cushenberry L, Rodriguez de Bittner M. New pharmacologic, diagnostic options advance diabetes care. Drug Topics. 2000; 4s-10s.
3. Lippman H. Diabetes today: better treatment, closer monitoring, more education. Diabetes Trends. 1999; 11: 5-10.
4. Herman ME, Moore RS. The importance of postprandial glucose to treatment and outcomes in patients with type 2 diabetes. Manag Care Interface. 2001; 14: 63-69.
5. Chernin T. New diabetes guidelines call for more aggressive screening. Drug Topics. 2001: 20.
6. Sherwin RS. Diabetes mellitus. In; Goldman L, Bennett JC, eds. Cecil Textbook of Medicine, 21st ed. Philadelphia, PA: WB Saunders Co. 2000: 1263-1271.
7. Insulin. Diabetes Forecast. 2002: 42-48.
8. White JR Jr, Campbell RK, Hirsch I. Insulin analogues: new agents for improving glycemic control. Postgrad Med. 1997; 101: 58-60, 63-65, 70.
9. McCulloch DK. Basic insulin regimens in diabetes mellitus. UpToDate 2001 http://www.uptodate.com/patient_info/topicpages/topics/1110D5.asp. Accessed December 6, 2001.
10. Nakhmanovich Y, Belenkaya R, Rozenfeld V. Insulin glargine in the management of diabetes mellitus. Pharm Ther. 2001; 26: 179-181.
11. Kesson CM, Bailie GR. Do diabetic patients inject accurate doses of insulin? Diabetes Care. 1981; 4: 333. LTE.
12. Burke JP, Williams K, Gaskill SP, et al. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Arch Intern Med. 1999; 159: 1450-1456.
13. Fagot-Campagna A, Pettitt DJ, Engelgau MM, et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr. 2000; 136: 664-672.
14. UBS Warburg Research. Estimated Growth of US Insulin Use (graph) 2001.
15. Cohen MR, Milo CM. High-alert medications and patient safety. Sentinel Event Alert. http://www.jcaho.orgledu_pub/sealert/seal1.html. Accessed April 17, 2002.
16. Phillips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm. 2001; 58: 1835-1841.
17. Prevention of medication errors in the pediatric inpatient setting. Pediatrics. 1998; 102: 428-430.
18. Kihm N. Tips for reducing your risk of a medication error. HPSO: Healthcare Providers Service Organization. 2.1 http://www.hpso.com/newsletters/1-99/pharm.html. Accessed December 7, 2001.
19. Kowiatek J, Skledar S, Potoski B. Insulin medication error reduction: a quality improvement initative. Hosp Pharm. 2001; 36: 629-638.
20. Lass G. Employer group sees HMOs as partners in medical error prevention. Manag Care. 2000; 13: 1-8.
21. McCulloch DK. Blood glucose monitoring in management of diabetes mellitus. UpToDate 2001 http://www.uptodate.com/patient_info/topicpages/topics/2081D5.asp.
22. Pick AJ, Jameson JL. Self-monitoring blood glucose improves glycemic control. Harrison's Online. www.harrisonsonline.com.
23. Molitch ME, Barr J, Callahan PL, et al. Self-monitoring of blood glucose. American Diabetes Association. 15 May 1996.
24. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from three days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001; 24: 1858-1862.
25. Kreinhofer M, Aufseesser-Stein M, Assal JP. Insulin injections: mistakes and errors made by patients and/or health care providers. Diabetes Res Clin Pract 1988; 4: 35-40.
26. Leibermeister H. Problems with outpatient treatment for elderly, insulin-injecting diabetics. Neunkirchen/Saar. 1-23.
27. Puxty JAH, Hunter DH, Burr WA. Accuracy of insulin injection in elderly patients. Lancet. 1983.
28. Bell DSH, Clements RS Jr, Perentesis G, Roddam R, Wagenknecht L. Dosage accruacy of self-mixed vs premixed insulin. Arch Intern Med. 1991; 151: 2265-2269.
29. Schade D, Arizigian T, Mitchell WJ, Griego G. Do compliant patients inject the prescribed dose of insulin? Diabetes. 1989; 38: Abs.
30. Solvig J, Christianson JS, Hansen B, et al. Needle length affects insulin deposition in normal and obese diabetes patients. Diabetes. 2001; 50: A13.
31. Chiarelli F, Severi F, Demarco F, et al. Needle length influences insulin leakage and pain perception in children and adolescents with diabetes. Diabetes. 2001; 50: A432.
32. Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient: overcoming obstacles to success. Postgrad Med. 1995; 97: 86-90, 93-96.
33. IMS RPP Device Trend 1996- YTD 2001. 2001.
34. Bohannon NJV. Insulin delivery using pen devices: simple-to-use tools may help young and old alike. Postgrad Med. 1999; 106: 57, 58, 61-64, 68.
35. Plevin S, Sadur C. Use of a prefilled insulin syringe (Novolin PrefilledTM) by patients with diabetes. Clin Ther. 1993; 15: 423-431.
36. Magills-Lewis J. The exploding problem of diabetes. Drug Topics. 2001: 49-56.
37. Graff MR, McClanahan MA. Assessment of patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998; 20: 486-496.
38. Kadiri A, Chraibi A, Marouan F, et al. Comparison of NovoPen® 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycemic agents. Diabetes Res Clin Pract. 1998; 41: 15-23.
39. Gnanalingham MG, Newland P, Smith CP. Accuracy and reproducibility of low dose insulin administration using pen-injectors and syringes. Arch Dis Child. 1998; 79: 59-62.
40. Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type I diabetes. Diabetes Care. 1999; 22: 137-140.
41. Keith KA, Nicholson DS, Roger D. Accuracy and precision of delivering low doses of insulin using syringes, pen injectors and a pump. Research day abstracts at the Midwestern Regional meeting of Pediatric Research. http://www.clevelandclinic.org/pediatrics/res/hpage9b.htm. Accessed December 7, 2001.
42. Coscelli C, Lostia S, Lunetta M, Nosari L, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995; 28: 173-177.
43. Corsi A, Torre E, Coronel G, et al. Pre-filled insulin pen in newly insulin-treated diabetic patients over 60 years old. Diab Nutr Metab. 1997; 10(2): 78-81.
44. Fox C, McKinnon C, Wall A, Lawton S. InnoLet® facilitates accurate, reliable insulin delivery in patients with visual impairment, and patients prefer it to alternative insulin delivery devices. Poster: American Diabetes Association. 2001.
45. Milewski M. An overview of insulin delivery: where are we headed in... the future? Jan. 2001. http://www.diabetesinterview.com/archive/jan01/jan2-01.shtml. Accessed December 7, 2001.
46. Harsch IA, Hahn EG, Konturek PC. Syringe, pen inhaler- the evolution of insulin therapy. Med Sci Monit. 2001. 7: 833-836.